Indefinite Delivery Contract SPE2D022D0002

Award Date 8/15/22
Last Date to Order 12/14/29
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued up to $0.00, is for the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide essential medications, over-the-counter drugs, vaccines, and critical care...
The indefinite delivery contract (IDC) SPM2DX11D2223 is a single-award contract held by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a total ceiling value of $4,999,999.00 and runs through March 31, 2015. Under this IDC, Amerisourcebergen has received numerous firm fixed-price delivery orders to deliver prescription...
This indefinite delivery contract (IDC) was awarded by the U.S. Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $500 million single-award IDC, with a period of performance from January 2005 through March 2015, serves as the primary vehicle for Amerisourcebergen to deliver specialty...
The Indefinite Delivery Contract (IDC) SPE2DR25D1961 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as a primary vehicle for DLA to procure specialty...
This Indefinite Delivery Contract (IDC) SPM20005D1024 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp (Vendor ID: TGxsdkVQRGhOYUpNR001SFhYREdNdz09), a major pharmaceutical distribution company. The contract is for the supply of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The IDC has a ceiling value of $4,900,000.00 and a period...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a $430 million single award Indefinite Delivery Contract (IDC) to Johnson & Johnson Health Care Systems Inc. (JJHCS), a division of Johnson & Johnson. The contract runs from May 2022 to May 2027 and allows for the delivery of a broad range of medical supplies including surgical and orthopedic implants, instruments, biological products, biomaterials, and other specialty medical items. These products are intended to...
The Indefinite Delivery Contract (IDC) SPE2DU25D3107 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,999,999 contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
The Indefinite Delivery Contract (IDC) SPE2DR25D3802 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs,...
The federal contract Indefinite Delivery Vehicle (IDV) is a $4.41 billion Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 to Janssen Pharmaceuticals, Inc. The contract covers the delivery of drugs, pharmaceuticals, and hematology-related products to federal agencies, with a focus on supporting the medical needs of military and veterans' healthcare systems. As the prime contractor, Janssen Pharmaceuticals, a for-profit manufacturer of pharmaceutical goods...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,999,999 single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract covers a vast array of pharmaceutical products,...
  • SPE2D022D0002
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The federal contract IDV award SPE2D022D0002 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to the prime contractor Janssen Pharmaceuticals, Inc. Janssen, a for-profit manufacturer of pharmaceutical goods, has been awarded two IDC contracts by DLA Troop Support Medical - one valued at over $12 million in 2019 and another $1.7 million contract in 2022. Under these IDCs, Janssen has received multiple firm fixed price delivery orders to provide branded pharmaceutical products and medical supplies, including itraconazole capsules, risperidone tablets, and haloperidol lactate injections, to military treatment facilities worldwide. The latest delivery orders valued at $20,481.55, $19,606.50, and $18,845.96 were issued in December 2024, December 2023, and December 2022 respectively, with no set-asides used. Janssen manufactures and ships these critical healthcare items from its facility in Titusville, New Jersey to support the Department of Defense's medical supply needs.

The purpose of these IDCs and associated delivery orders is to ensure reliable access to vital pharmaceutical and medical products for the U.S. military. As a key supplier, Janssen's role is to manufacture and distribute these branded drug items to military treatment facilities globally under firm fixed price terms. The contracts prioritize uninterrupted access to these essential healthcare goods without the use of any socioeconomic set-asides, given Janssen's status as a commercial pharmaceutical manufacturer.

Generated 3/20/25, 9:48 AM